23 research outputs found
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study
Hybrid capture II (HC II) test for oncogenic human papillomaviruses (HPV) was carried out in a cohort of 4284 women at their first clinical visit. Overall prevalence of HPV was 17.1%, decreasing with age from 33.9% among women below 20 years to only 11.0% among those older than 41 years. HPV prevalence was significantly higher among current smokers (odds ratio [OR] ¼ 1.31; 95% CI 1.1–1.6), in women with two or more lifetime sexual partners (OR ¼ 1.9; 95% CI 1.6–2.4), and those women with two or more sexual partners during the past 12 months prior to examination (OR ¼ 1.6; 95% CI 1.2–2.2). HPV detection increased in parallel with increasing cytologic abnormality, being highest in women with high-grade squamous intraepithelial lesion (P ¼ 0.001). Specificity of the HPV test in detecting histologically confirmed cervical disease was 85% (95% CI 83.9–86.1). Sensitivity of the HPV test in detecting histologic abnormalities increased
in parallel with disease severity, ranging from 51.5% for cervical intraepithelial neoplasia (CIN) 1 to 96.5% for CIN 3 and 100.0% for cancer, with respective decline of positive predictive value. These data suggest
that HPV testing with HC II assay might be a viable screening tool among this population with relatively high prevalence of cervical disease
Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America
Objectives: To assess the performance indicators of visual inspection with acetic acid (VIA) and visual
inspection with Lugol’s iodine (VILI) in four Latin American centres participating in the ongoing Latin
AMerican Screening (LAMS) study, in settings with moderate incidence of cervical disease and with
poorly to moderately well-organized cervical cancer screening.
Setting: Three Brazilian centres (São Paulo, Campinas and Porto Alegre) and one Argentine centre
(Buenos Aires) recruited a total of 11,834 healthy women to undergo VIA, VILI, conventional Pap
smear and Hybrid Capture II (HCII).
Methods: Women who had a positive result from any of these tests were subjected to colposcopy and
biopsies (if necessary), and women with high-grade cervical intraepithelial neoplasia (CIN) were
properly treated. To control for verification bias, 5% of women with normal tests were referred for
colposcopy, as were 20% of HCII-negative women.
Results: Data on VIA (n = 11,834), VILI (n = 2994), conventional Pap smear (n = 10,138) and HCII
(n = 4195) were available for test comparisons, calculating sensitivity, specificity, and positive and
negative predictive values. Overall test positivity was 11.6% for VIA, 23.0% for VILI, 2.2% for Pap
smear (LSIL threshold), 1.1% for Pap smear (HSIL threshold) and 17.1% for HCII. VIA was positive in
61.8% of the women with CIN 1, 57.0% of those with CIN 2, 35.0% of women with CIN 3 and in 21
of 28 (75%) of women with cancer. Approximately 10% of women with no detectable disease had an
abnormal VIA. Regarding VILI, 83.3% of women diagnosed with CIN 1 and 62.5% of those with CIN
3 had an abnormal test. VILI failed to detect one of three cases of cancer. Both the sensitivity, specificity
and positive predictive value of VIA and VILI in detecting CIN 2 or CIN 3 could be significantly
improved depending on the combination with Pap smear or HCII (sensitivity up to 100.0% and
specificity up to 99.8%).
Conclusions: The LAMS study failed to reproduce the performance figures obtained with VIA and VILI
(as stand-alone tests) in some other settings, where the prevalence of cervical disease was higher.
However, a combined use of VIA or VILI with the Pap test or HCII allowed specific detection of cervical
abnormalities.European Union (EU) - INCO-DEV Programme - Contract# ICA4-CT-2001-10013
Toxicity of abamectin to the terrestrial isopod Porcellio scaber (Isopoda, Crustacea).
To determine effects of the antiparasitic veterinary drug abamectin on the isopod Porcellio scaber, animals were exposed for 21 days to Lufa 2.2 soil spiked at concentrations of 3-300 mg/kg dry soil. After exposure, abamectin residues in the isopods were analysed using a novel analytical method. Toxicity was evaluated on different levels of biological organisation: biochemical, cellular and the individual organism. Measurements included glutathione S-transferase (GST) activity and stability of cell membranes in the digestive gland, animal mass gain or loss, food consumption, behaviour and mortality. LC50 for the effect of abamectin on survival of P. scaber was 71 mg/kg dry soil. The most obvious sublethal effects were reduced food consumption and decreased body mass (NOEC 3 mg/kg dry soil). Additionally, loss of digging activity and reduced GST activity (NOEC 30 mg/kg dry soil) and cell membrane destabilization (NOEC 10 mg/kg dry soil) were recorded. Abamectin only slightly accumulated in the isopods, with bioaccumulation factors always being <0.1. Based on these results and current information on environmental levels of abamectin, it is not likely that isopods will be affected by abamectin, but further studies with exposure through faeces are recommended. © 2010 Springer Science+Business Media, LLC
Exposure assessment of male recruits in Slovenia to cadmium and lead due to biological monitoring
Challenges to evidence synthesis and identification of data gaps in human biomonitoring
The increasing number of human biomonitoring (HBM) studies undertaken in recent decades has brought to light the need to harmonise procedures along all phases of the study, including sampling, data collection and analytical methods to allow data comparability. The first steps towards harmonisation are the identification and collation of HBM methodological information of existing studies and data gaps. Systematic literature reviews and meta-analyses have been traditionally put at the top of the hierarchy of evidence, being increasingly applied to map available evidence on health risks linked to exposure to chemicals. However, these methods mainly capture peer-reviewed articles, failing to comprehensively identify other important, unpublished sources of information that are pivotal to gather a complete map of the produced evidence in the area of HBM. Within the framework of the European Human Biomonitoring Initiative (HBM4EU) initiative—a project that joins 30 countries, 29 from Europe plus Israel, the European Environment Agency and the European Commission—a comprehensive work of data triangulation has been made to identify existing HBM studies and data gaps across countries within the consortium. The use of documentary analysis together with an up-to-date platform to fulfil this need and its implications for research and practice are discussed. © 2021 by the authors. Licensee MDPI, Basel, Switzerland
Evaluation of the ability to make non-invasive estimation of muscle contractile properties on the basis of the muscle belly response
Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience
Pros and Cons of Clinical Basophil Testing (BAT)
PURPOSE OF REVIEW: We review basophil testing by flow cytometry with an emphasis on advantages and disadvantages. RECENT FINDINGS: There are many tools available to assess the presence and severity of allergic diseases in patients. For 50 years, peripheral blood basophils have been used as tools to study these diseases. It is a very accessible cell that binds IgE antibody and secretes the classical mediators responsible for the symptoms of allergic reactions. In the last decade, an even more accessible methodology, using flow cytometry, has been developed to enhance the ability to use basophils for both mechanistic and clinical diagnostics. Basophil testing has been included in diagnostics for different forms of allergies as well as to monitor disease status. A variety of studies have begun to establish both precise methods and their clinical relevance for disease diagnosis, but there remain some important questions on how to take optimal advantage of the behaviours of basophils